0001104659-23-021541.txt : 20230214
0001104659-23-021541.hdr.sgml : 20230214
20230214160615
ACCESSION NUMBER: 0001104659-23-021541
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230210
FILED AS OF DATE: 20230214
DATE AS OF CHANGE: 20230214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jin David
CENTRAL INDEX KEY: 0001930732
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35366
FILM NUMBER: 23628887
MAIL ADDRESS:
STREET 1: C/O AVENUE THERAPEUTICS, INC.
STREET 2: 1140 AVENUE OF THE AMERICAS, FLOOR 9
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Fortress Biotech, Inc.
CENTRAL INDEX KEY: 0001429260
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 205157386
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1111 KANE CONCOURSE
STREET 2: SUITE 301
CITY: BAY HARBOR ISLANDS
STATE: FL
ZIP: 33154
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 1111 KANE CONCOURSE
STREET 2: SUITE 301
CITY: BAY HARBOR ISLANDS
STATE: FL
ZIP: 33154
FORMER COMPANY:
FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC
DATE OF NAME CHANGE: 20080310
4
1
tm236803-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2023-02-10
0
0001429260
Fortress Biotech, Inc.
FBIO
0001930732
Jin David
C/O FORTRESS BIOTECH, INC.
1111 KANE CONCOURSE SUITE 301
BAY HARBOR ISLANDS
FL
33154
0
1
0
0
Chief Financial Officer
COMMON STOCK, PAR VALUE $0.001
2023-02-10
4
P
0
35928
0.835
A
1438757
D
The total holdings include 1,350,000 shares underlying deferred restricted stock units.
/s/ David Jin
2023-02-14